Haleon to sell non-US nicotine replacement therapy portfolio to Dr. Reddy’s Laboratories

Haleon to sell non-US nicotine replacement therapy portfolio to Dr. Reddy’s Laboratories

Haleon plc, a prominent player in the global healthcare market, has reached an agreement to sell its nicotine replacement therapy (NRT) business outside of the United States to Dr. Reddy’s Laboratories SA, a subsidiary of Dr. Reddy’s Laboratories Limited. The deal, valued at £500 million, marks a strategic shift for Haleon, allowing it to streamline […]

HSBC to sell Argentine business to Grupo Financiero Galicia for $550m

HSBC to sell Argentine business to Grupo Financiero Galicia for $550m

HSBC Latin America B.V., a subsidiary of HSBC Holdings plc, has finalized the sale of its Argentine operations to Grupo Financiero Galicia, marking a significant transaction in the banking sector. The deal, valued at $550 million, involves the complete transfer of HSBC’s Argentine business, including banking, asset management, and insurance sectors, along with $100 million […]